Combination of antiangiogenic therapy using the mTOR-inhibitor RAD001 and low dose chemotherapy for locally advanced and/or metastatic pancreatic cancer

To determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLT) of escalating doses of Gemcitabine in combination with Everolimus.

Kusajili – Centralise les essais cliniques mondiaux